WHO ICTRP trial
A phase II trial of carboplatin and paclitaxel compared with carboplatin or…
EUCTR2006-000126-31-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-000126-31-IT |
|---|---|
| Public title | A phase II trial of carboplatin and paclitaxel compared with carboplatin or gemcitabine paclitaxel "induction" followed by carboplatin/paclitaxel/gemcitabine in patients with suboptimally resected stage III or IV ovarian carcinoma - ND |
| Scientific title | A phase II trial of carboplatin and paclitaxel compared with carboplatin or gemcitabine paclitaxel "induction" followed by carboplatin/paclitaxel/gemcitabine in patients with suboptimally resected stage III or IV ovarian carcinoma - ND |
| Primary sponsor | POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Epithelial ovarian carcinoma MedDRA version: 6.1 Level: PT Classification code 10033163 |
| Interventions | Trade Name: GEMZAR*INFUS 1FL 1G POLV Pharmaceutical Form: Powder for infusion* INN or Proposed INN: Gemcitabine CAS Number: 122111-03-9 Concentration unit: % percent Concentration type: equal Concentration number: 1- Trade Name: TAXOL*1FL… |
| Registration date | Jul 9, 2007 |
| Secondary IDs | 1401 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: